Related Experiment Video
Updated: May 22, 2026
14:04
Detection of Protein Aggregation using Fluorescence Correlation Spectroscopy
Published on: April 25, 2021
Detection of α-synuclein aggregates by fluorescence microscopy
S Hübinger1, O Bannach, S A Funke
1Institut für Physikalische Biologie, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
Rejuvenation Research
|April 27, 2012
Summary
Parkinson disease (PD) diagnosis may be improved by quantifying alpha-synuclein aggregates. This study introduces a method to detect these protein clumps, potentially enabling earlier detection before irreversible neuron damage occurs.
Area of Science:
- Neurodegenerative diseases
- Neuroscience
- Biomarker discovery
Background:
- Parkinson disease (PD) is a common age-related neurodegenerative disorder characterized by motor deficits.
- PD pathogenesis involves dopaminergic neuron loss and alpha-synuclein protein misfolding and aggregation.
- Current diagnosis relies on clinical symptoms, appearing after significant, irreversible neuronal damage.
Purpose of the Study:
- To identify a reliable biomarker for the preclinical diagnosis of Parkinson disease.
- To develop and validate a method for quantifying single alpha-synuclein aggregates as a potential PD biomarker.
Main Methods:
- Development of a novel approach to detect and quantify individual alpha-synuclein aggregates.
- Application of the method to assess alpha-synuclein aggregate levels relevant to Parkinson disease.
Main Results:
- Successful quantification of single alpha-synuclein aggregates.
- Demonstration of alpha-synuclein aggregates as a potential biomarker for Parkinson disease.
Conclusions:
- Quantifying alpha-synuclein aggregates offers a promising avenue for the preclinical diagnosis of Parkinson disease.
- This approach could lead to earlier intervention and improved patient outcomes by detecting the disease before substantial neuron loss.
